Nitroject

the effectiveness of treatment outweighs the potential risk to the fetus or child). When using transdermal forms of the drug, contact with eyes and mucous membranes must be avoided.

Nitroject is a drug manufactured in India by Sun Pharmaceutical Industries Ltd. It belongs to the group of antianginal agents - nitrates and nitrites. The international name of the drug is Nitroglycerin. It is used to treat angina pectoris, including Prinzmetal angina, acute myocardial infarction, congestive heart failure, controlled hypotension during surgery, pulmonary edema, and central retinal artery occlusion.

Nitroject is available in the form of a solution for intravenous injection of 0.5% containing the active substance - Nitroglycerin. The drug has a number of contraindications, including hypersensitivity, hypotension, collapse, myocardial infarction with severe hypotension or collapse, cerebral hemorrhage, increased intracranial pressure, cerebral ischemia, cardiac tamponade, toxic pulmonary edema, severe aortic stenosis, and angle-closure glaucoma.

When using Nitroject, side effects may occur, such as headache, dizziness, a feeling of fullness in the head, palpitations, hypotension, collapse, orthostatic hypotension, methemoglobinemia and paradoxical effects - an attack of angina, ischemia, up to the development of myocardial infarction and sudden death.

Interaction of Nitroject with other drugs may lead to increased hypotensive and systemic vasodilating effects. Overdose may cause serious symptoms, including headache, dizziness, palpitations, nausea and vomiting, hypotension, fever or chills, increased sweating, dyspnea, increased intracranial pressure and methemoglobinemia.

When using Nitroject, you must follow some special instructions. In the acute period of myocardial infarction and with the development of acute heart failure, the drug should be prescribed under strict hemodynamic monitoring. It should be used with caution in patients with aortic and mitral stenosis, in patients with hypovolemia and hypovolemic shock, as well as in patients taking other drugs that may enhance the hypotensive effect. When using Nitroject, concomitant use with alcohol should be avoided, as this may lead to an enhanced hypotensive effect and an increased risk of side effects.

Overall, Nitroject is an effective drug for the treatment of angina and other cardiovascular diseases, but its use should be limited to qualified professionals only and under their strict supervision. Patients should carefully follow the doctor's recommendations and not exceed the doses indicated in the instructions for the drug to avoid possible side effects and complications.